Abstract
Multiple chemical sensitivity (MCS) onset in minors can greatly impact learning and future employment. This study investigated the prevalence of MCS and related factors in high school students to determine whether it was the same as in adults. A comprehensive survey was conducted on 80 high schools in Gunma Prefecture, Japan. The survey incorporated the Quick Environmental Exposure and Sensitivity Inventory, as well as items related to allergies, the living environment, and lifestyle. Of the 4630 students analyzed, according to Hojo’s cut-off value, 9.0% were classified as high-risk for MCS and 77.9% reported some allergy-like symptoms. Significant factors associated with elevated MCS risk included female sex, having various allergic conditions, having experienced living in a new home or home renovations or extensions, proximity to environmental stressors (freeways, national highway, factories, rubbish dumps, or sources of offensive odors), insufficient physical activity (exercising less than once a week outside of physical education classes), having cold hands and feet, being fatigued, having a bedtime earlier than 11 p.m., and having moderate–frequent subjective stress. Overall, 9.0% of high school students in Japan are at high risk for MCS. Enhancing awareness of MCS-like symptoms and addressing allergies, living environments, and lifestyle habits may mitigate these symptoms.
Keywords: multiple chemical sensitivity, high school students, QEESI, lifestyle behaviors, allergies
1. Introduction
Multiple chemical sensitivity (MCS), also known as environmental hypersensitivity, idiopathic environmental intolerance, and toxicant-induced tolerance loss, is a condition caused by prolonged exposure to small amounts of chemicals that are not normally considered harmful [1,2,3,4,5,6]. For example, fabric softeners and new building materials are not typically thought to have any effect on the human body. However, individuals with MCS can have severe reactions to these substances, causing a variety of symptoms that significantly impact their daily lives.
The symptoms of MCS include headaches, dizziness, difficulty breathing, palpitations, gastrointestinal symptoms, fatigue, depressive symptoms, and cognitive impairment [1,2,3,4]. In Japan, MCS was included in the 10th edition of the International Classification of Diseases in 2009; however, the etiology, diagnosis, and treatment of MCS remain controversial [1,5,7,8], and clear physiological diagnostic criteria have not been established. The 1999 consensus provides the most comprehensive case definition [1,7,9,10], and recommends the Environmental Exposure and Sensitivity Inventory (EESI) and its shortened version, the QEESI, for screening MCS [11].
Although there are few reports that calculate the prevalence of MCS based on clinical assessment or the 1999 consensus criteria, existing studies have provided some estimates. The estimated prevalence is 0.5–12.8%, based on medical diagnosis, or 0.9–33.0%, based on self-reported information [5]. These figures suggest that a significant number of individuals experience and are aware of MCS-like symptoms, despite some debate about the condition’s existence. Between 2002 and 2016, the number of individuals with MCS-like symptoms increased two- to three-fold in the United States [4]. Although the onset of MCS in minors can significantly impact educational outcomes and future employment, most research has predominantly focused on adults [12].
In Japan, the prevalence of MCS was 12.4%, based on a survey targeting first-year elementary school students to third-year junior high school students [12]. The issue of health problems caused by school facilities, including how to deal with children with chemical sensitivities, is known as the “sick school problem”, prompting cities and prefectures to create countermeasure manuals. However, there are few studies on the prevalence of chemical sensitivity in minors and factors related to its onset, and there have been no studies targeting high school students. High school students, with their still-developing bodies and prolonged exposure to communal environments like schools, may exhibit distinct prevalence rates and risk of MCS compared with adults; however, this potential difference remains unexplored due to a lack of research. In Japan, high school students are choosing their career paths; however, the prevalence of MCS, the degree of hypersensitivity to chemical substances, and related factors that may affect career choices and studies remain unclear.
Therefore, in this study, we used the globally recognized QEESI [13,14,15,16,17,18] to screen for chemical sensitivity among high school students. Our objectives were to calculate the proportion of high school students at high risk of MCS and examine the related factors. Our findings indicate that a significant proportion of high school students are at high risk of MCS, with several lifestyle and environmental factors associated with increased risk. These results highlight the importance of addressing chemical sensitivity in adolescent populations and suggest potential areas for intervention and further research.
2. Materials and Methods
2.1. Participants
This study surveyed high school students from Gunma Prefecture in Japan, covering 80 (68 public schools and 12 private schools) of the 87 high schools listed on the Gunma Prefectural Education Center website. Seven special high schools were excluded (correspondence high schools and residential boarding high schools).
2.2. Survey Method
To calculate the percentage of high school students who were highly sensitive to chemical substances, we used the QEESI [11], which has been used both in Japan [19,20,21,22,23,24] and internationally [16,17,25,26,27,28,29,30,31,32,33] as a screening tool for MCS. The QEESI was developed by Miller and Prihoda in the USA in 1999 for screening MCS patients and evaluating the effectiveness of treatment, and for epidemiological research on MCS using self-reporting questionnaires. Currently, it has been translated into 16 languages; in Japan, it was translated by Ishikawa and Miyata in 1998, and its reliability and validity were confirmed by Hojo et al. in 2003. The QEESI results are classified based on the cutoff value. Commonly used cutoff values in MCS research include those developed by Miller et al. [11], Hojo et al. [19], and Skovbjerg et al. [18]. For this study, we opted to use the cutoff value established by Hojo et al., which was specifically tailored for Japan.
We requested study cooperation from the 80 target schools by mail. Questionnaires were sent only to the high schools that consented to cooperate, and the survey was implemented after the aims and methods were explained to the students by teachers at each high school. The questionnaires were returned to the researchers after being collected at each high school. Data collection was conducted from July to October 2013.
2.3. Survey Content
The questionnaire, which included 100 questions, was designed to be answered in less than 15 min. It covered the following surveyed items:
-
(1)
Attributes (e.g., sex, school year), diagnosis of sick house syndrome (SHS), and diagnosis of MCS.
-
(2)
Allergies, including hay fever, atopic dermatitis, asthma, hives, and other allergies, assessing whether the respondent currently had symptoms or had symptoms in the past.
-
(3)
Living environment (i.e., whether the respondent lived in a new building or a building undergoing renovations) and details about the environment surrounding the home.
-
(4)
Lifestyle (including various aspects of daily habits and routine).
-
(5)
QEESI [19] sections, specifically QEESI Q1 (Chemical Intolerance), Q3 (Symptom Severity), and Q5 (Impact on Life). Each section comprised 10 questions, scored on a 0–10 scale, resulting in a total score range of 0 to 100 points for Q1, Q3, and Q5.
2.4. Statistical Analysis
Hojo’s cut-off value [19] was used to identify high school students at high risk of MCS (hereinafter referred to as the MCS high-risk group) and participants with Q1, Q3, and Q5 scores ≥40, ≥20, and ≥10, respectively, were assigned to the “MCS high-risk group”.
SPSS version 21 (IBM Corps., Armonk, NY, USA) was used to compare the groups. Before selecting the appropriate statistical tests, we first assessed the normality of our data using the Shapiro–Wilk test. This step was crucial in determining whether to use parametric or non-parametric methods in our subsequent analyses. As a result, the Mann–Whitney U test was used for continuous data, and Pearson’s Chi-squared test was used for categorical data. In our cross-tabulation analyses, we applied a specific criterion for using Fisher’s exact test. This test was employed when there were cells with expected frequencies less than 1, or when expected frequencies less than 5 accounted for 20% or more of the total cells. This approach ensured accurate analysis in cases where the assumptions of the Chi-squared test might not have been met due to low expected cell counts. The crude odds ratio (COR), adjusted odds ratio (AOR), and 95% confidence interval (95% CI) were calculated. In the univariate analysis, items with p values < 0.25 were selected as independent variables, and a logistic regression analysis was conducted using the variable increase method (likelihood ratio). The level of significance was set at less than 5%. To evaluate multicollinearity, the variance inflation factor (VIF) was obtained. When the VIF was 3 or more, it was determined that there was collinearity between the independent variables, and the variable was subsequently excluded.
2.5. Ethical Considerations
Prior to the survey, the study was explained to the participants by their teachers at each high school, and an explanation and consent form were distributed. It was explained to participants that “participation/cooperation in the study is voluntary”, “consent to participate in the study is granted through submission of the questionnaire”, “the survey is anonymous”, and “the acquired data would be promptly digitized, strictly controlled by storage in a locked storage cabinet, and destroyed as soon as the survey results were compiled”. After the questionnaire was completed, the students placed their questionnaires into sealable individual envelopes, which were then sealed and placed into a collection bag.
This study was conducted in accordance with the principles outlined in the Declaration of Helsinki of 1975, revised in 2013, and approved by the Institutional Review Board of Gunma PAZ University (protocol code: 13–17; date of approval: 24 July 2013).
3. Results
3.1. Participant Characteristics
Twenty-one schools (26.3%) agreed to participate in this study. Questionnaires were distributed to 6144 students and responses were obtained from 5775 students (response rate, 94.0%). The data of 4630 students without missing data (effective response rate, 80.2%) were analyzed (Figure 1).
Figure 1.
Flow chart of participant selection.
Of the 4630 students, 2413 were male (52.1%) and 2217 were female (47.9%); 2342 students were in their first year of high school (50.6%), 1639 in their second year (35.4%), and 649 in their third year (14.0%) (Table 1).
Table 1.
Characteristics of the participants.
| Characteristics | Total Number n = 4630 (100%) |
Control Group n = 4215 (91.0%) |
High-Risk Group n = 415 (9.0%) |
p-Value 1 | |||
|---|---|---|---|---|---|---|---|
| N | (%) | n | (%) | n | (%) | ||
| Sex | <0.001 | ||||||
| Male | 2413 | (52.1) | 2238 | (53.1) | 175 | (42.2) | |
| Female | 2217 | (47.9) | 1977 | (46.9) | 240 | (57.8) | |
| Grade | 0.711 | ||||||
| Sophomore | 2342 | (50.6) | 2129 | (50.5) | 213 | (51.3) | |
| Junior | 1639 | (35.4) | 1499 | (35.6) | 140 | (33.7) | |
| Senior | 649 | (14.0) | 587 | (13.9) | 62 | (14.9) | |
| Course | 0.189 | ||||||
| General | 3013 | (65.1) | 2734 | (64.9) | 279 | (67.2) | |
| Commercial | 568 | (12.3) | 522 | (12.4) | 46 | (11.1) | |
| Industrial | 628 | (13.6) | 574 | (13.6) | 54 | (13.0) | |
| Another | 421 | (9.1) | 385 | (9.1) | 36 | (8.7) | |
1 Pearson’s Chi-squared test.
Using Hojo’s cut-off value [19], a total of 415 students (9.0%) were assigned to the MCS high-risk group. The remaining 4215 students (91.0%) were considered as the control group. Factors that affected the MCS high-risk group and the control group were then investigated.
3.2. Sex, Diagnosis, and Symptoms
The correlation between sex and the MCS high-risk group is shown in Table 2. The percentage of females in the control group versus the MCS high-risk group was 46.9% versus 57.8%, respectively (p < 0.001, COR: 1.55).
Table 2.
Comparison of sex and allergic factors between the MCS high-risk group and control group.
| Comparative Items | Total Number n = 4630 (100%) |
Control Group n = 4215 (91.0%) |
High-Risk Group n = 415 (9.0%) |
Crude Odds Ratio (95% CI 3) |
p-Value 1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| n | (%) | N | (%) | n | (%) | ||||
| Sex | Male | 2413 | (52.1) | 2238 | (53.1) | 175 | (42.2) | 1.00 | <0.001 |
| Female | 2217 | (47.9) | 1977 | (46.9) | 240 | (57.8) | 1.55 | ||
| (1.27–1.90) | |||||||||
| Health condition | |||||||||
| SHS diagnosis | No | 4611 | (99.6) | 4201 | (99.7) | 410 | (98.8) | 1.00 | 0.023 |
| Yes | 19 | (0.4) | 14 | (0.3) | 5 | (1.2) | 3.67 | ||
| (1.31–10.21) | |||||||||
| MCS diagnosis | No | 4606 | (99.5) | 4195 | (99.5) | 411 | (99.0) | 0.267 | |
| Yes | 24 | (0.5) | 20 | (0.5) | 4 | (1.0) | |||
| Allergies 2 | No | 1023 | (22.1) | 950 | (22.5) | 73 | (17.6) | 1.00 | 0.022 |
| Yes | 3607 | (77.9) | 3265 | (77.5) | 342 | (82.4) | 1.36 | ||
| (1.05–1.77) | |||||||||
| Hay fever | No | 1799 | (38.9) | 1656 | (39.3) | 143 | (34.5) | 0.054 | |
| Yes | 2831 | (61.1) | 2559 | (60.7) | 272 | (65.5) | |||
| Atopic dermatitis | No | 3788 | (81.8) | 3468 | (82.3) | 320 | (77.1) | 1.00 | 0.009 |
| Yes | 842 | (18.2) | 747 | (17.7) | 95 | (22.9) | 1.38 | ||
| (1.08–1.76) | |||||||||
| Asthma | No | 3852 | (83.2) | 3513 | (83.3) | 339 | (81.7) | 0.389 | |
| Yes | 778 | (16.8) | 702 | (16.7) | 76 | (18.3) | |||
| Mold/dust/mite | No | 3379 | (73.0) | 3100 | (73.5) | 279 | (67.2) | 1.00 | 0.006 |
| allergies | Yes | 1251 | (27.0) | 1115 | (26.5) | 136 | (32.8) | 1.36 | |
| (1.09–1.68) | |||||||||
| Urticaria | No | 3198 | (69.1) | 2934 | (69.6) | 264 | (63.6) | 1.00 | 0.012 |
| Yes | 1432 | (30.9) | 1281 | (30.4) | 151 | (36.4) | 1.31 | ||
| (1.06–1.62) | |||||||||
| Food allergies | No | 3991 | (86.2) | 3653 | (86.7) | 338 | (81.4) | 1.00 | 0.003 |
| Yes | 639 | (13.8) | 562 | (13.3) | 77 | (18.6) | 1.48 | ||
| (1.14–1.93) | |||||||||
| Drug allergies | No | 4503 | (97.3) | 4108 | (97.5) | 395 | (95.2) | 1.00 | 0.007 |
| Yes | 127 | (2.7) | 107 | (2.5) | 20 | (4.8) | 1.94 | ||
| (1.19–3.17) | |||||||||
| Metal allergies | No | 4513 | (97.5) | 4121 | (97.8) | 392 | (94.5) | 1.00 | <0.001 |
| Yes | 117 | (2.5) | 94 | (2.2) | 23 | (5.5) | 2.57 | ||
| (1.61–4.11) | |||||||||
1 Pearson’s Chi-squared test or Fisher’s exact test. 2 Having one of the following allergies, namely hay fever, atopic dermatitis, asthma, mold/dust/mite allergies, urticaria, food allergies, drug allergies, and metal allergies, was defined as Yes. 3 CI, confidence interval.
The correlations of the MCS high-risk group with diagnosis, subjective symptoms, and allergy-like symptoms are shown in Table 2. Among the entire cohort, 0.4% (n = 19) were diagnosed with SHS, and 0.5% (n = 24) were diagnosed with MCS. A significant correlation was found between “having an SHS diagnosis” and the MCS high-risk group (p = 0.023, COR: 3.67); however, no significant correlation was found between “having an MCS diagnosis” and being in the MCS high-risk group (p = 0.267).
Of the 4630 participants, 61.1% had hay fever, 30.9% had urticaria, 27.0% had mold/dust/mite allergies, 18.2% had atopic dermatitis, and 16.8% had asthma. Overall, 77.9% of the students experienced allergy-like symptoms. Students with allergies accounted for 77.5% of the control group and 82.4% of the MCS high-risk group, and allergies were significantly related to the MCS high-risk group (p = 0.022, COR: 1.36).
In addition, the MCS high-risk group was associated with atopic dermatitis (p = 0.009, COR: 1.38), mold/dust/mite allergies (p = 0.006, COR: 1.36), urticaria (p = 0.012, COR: 1.31), food allergies (p = 0.003, COR: 1.48), drug allergies (p = 0. 007, COR: 1.94), and metal allergies (p < 0.001, COR: 2.57). Metal allergies showed the highest COR.
3.3. Number of Allergy-like Symptoms
To examine whether the allergy-like symptoms were diverse, we counted the number of diseases with allergy-like symptoms, including hay fever, atopic dermatitis, asthma, mold/dust/mite allergies, urticaria, food allergies, drug allergies, and metal allergies. If all were applicable, this counted as eight allergy-like symptoms. We found that the MCS high-risk group tended to have a higher percentage of students with allergy-like symptoms than the control group (Table 3).
Table 3.
Comparison of the numbers of allergy-like symptoms between groups.
| Comparative Items | Total Number n = 4630 (100%) |
Control Group n = 4215 (91.0%) |
High-Risk Group n = 415 (9.0%) |
p-Value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | ||||||||
| Count or allergy-like symptoms 1 | Median value 1.0 [1.0–3.0] | Median value 2.0 [1.0–3.0] | <0.001 2 | |||||||
| 1.7 ± 1.5 | 2.1 ± 1.6 | |||||||||
| No allergies | 1023 | (22.1) | 950 | (22.5) | 73 | (17.6) | ||||
| Has allergies | 3607 | (77.9) | 3265 | (77.5) | 342 | (82.4) | ||||
| One allergy-like symptom | 1351 | (29.2) | 1242 | (29.5) | 109 | (26.3) | ||||
| Two allergy-like symptoms | 1029 | (22.2) | 936 | (22.2) | 93 | (22.4) | ||||
| Three allergy-like symptoms | 637 | (13.8) | 577 | (13.7) | 60 | (14.5) | <0.001 3 | |||
| Four allergy-like symptoms | 349 | (7.5) | 305 | (7.2) | 44 | (10.6) | ||||
| Five allergy-like symptoms | 165 | (3.6) | 144 | (3.4) | 21 | (5.1) | ||||
| Six allergy-like symptoms | 60 | (1.3) | 49 | (1.2) | 11 | (2.7) | ||||
| Seven allergy-like symptoms | 12 | (0.3) | 8 | (0.2) | 4 | (1.0) | ||||
| Eight allergy-like symptoms | 4 | (0.1) | 4 | (0.1) | 0 | (0.0) | ||||
1 We counted the number of allergy-like symptoms, including hay fever, atopic dermatitis, asthma, mold/dust/mite allergies, urticaria, food allergies, drug allergies, and metal allergies. If all were applicable, this counted as eight allergy-like symptoms. 2 Mann–Whitney U Test. 3 Pearson’s Chi-squared test.
3.4. Residential Environment
The comparison of residential environmental factors between the MCS high-risk group and the control group is shown in Table 4. The following items were significantly correlated with the MCS high-risk group: the number of times the respondent had experienced moving into a new home; home renovations or extensions; and proximity to environmental stressors, including living close to a freeway, national highway, factory, rubbish dump, or a source of offensive odors.
Table 4.
Comparison of residential environmental factors between the groups.
| Comparative Items | Total Number n = 4630 (100%) |
Control Group n = 4215 (91.0%) |
High-Risk Group n = 415 (9.0%) |
(95% CI 2) Crude Odds Ratio |
p-Value 1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | ||||
| Number of times the respondent has experienced moving into a new home | (1.01–1.53) | 0.036 | |||||||
| Zero times | 2157 | (46.6) | 1984 | (47.1) | 173 | (41.7) | 1.00 | ||
| One time or more | 2473 | (53.4) | 2231 | (52.9) | 242 | (58.3) | 1.24 | ||
| Have you experienced home renovations, extensions, or redecorating? | (1.06–1.68) | 0.015 | |||||||
| No | 3642 | (78.7) | 3335 | (79.1) | 307 | (74.0) | 1.00 | ||
| Yes | 988 | (21.3) | 880 | (20.9) | 108 | (26.0) | 1.33 | ||
| Indoor environment | |||||||||
| Mold/condensation | 1906 | (41.2) | 1723 | (40.9) | 183 | (44.1) | 0.204 | ||
| Tatami room | 4087 | (88.3) | 3713 | (88.1) | 374 | (90.1) | 0.220 | ||
| Is there a freeway or national highway near your house? | (1.01–1.53) | 0.044 | |||||||
| No | 3078 | (66.5) | 2821 | (66.9) | 257 | (61.9) | 1.00 | ||
| Yes | 1552 | (33.5) | 1394 | (33.1) | 158 | (38.1) | 1.25 | ||
| Are there high-voltage power lines near your house? | 0.839 | ||||||||
| No | 3815 | (82.4) | 3475 | (82.4) | 340 | (81.9) | |||
| Yes | 815 | (17.6) | 740 | (17.6) | 75 | (18.1) | |||
| Is there an intersection near your house? | 0.196 | ||||||||
| No | 2061 | (44.5) | 1889 | (44.8) | 172 | (41.4) | |||
| Yes | 2569 | (55.5) | 2326 | (55.2) | 243 | (58.6) | |||
| Is there a railway near your house? | 0.570 | ||||||||
| No | 3661 | (79.1) | 3328 | (79.0) | 333 | (80.2) | |||
| Yes | 969 | (20.9) | 887 | (21.0) | 82 | (19.8) | |||
| Is there a factory near your house? | (1.01–1.05) | 0.045 | |||||||
| No | 3544 | (76.5) | 3243 | (76.9) | 301 | (72.5) | 1.00 | ||
| Yes | 1086 | (23.5) | 972 | (23.1) | 114 | (27.5) | 1.26 | ||
| Is there a park near your house? | 0.135 | ||||||||
| No | 2174 | (47.0) | 1994 | (47.3) | 180 | (43.4) | |||
| Yes | 2456 | (53.0) | 2221 | (52.7) | 235 | (56.6) | |||
| Is there a cropping field or orchard near your house? | 0.401 | ||||||||
| No | 1853 | (40.0) | 1695 | (40.2) | 158 | (38.1) | |||
| Yes | 2777 | (60.0) | 2520 | (59.8) | 257 | (61.9) | |||
| Is there a golf course near your house? | 0.179 | ||||||||
| No | 4272 | (92.3) | 3882 | (92.1) | 390 | (94.0) | |||
| Yes | 358 | (7.7) | 333 | (7.9) | 25 | (6.0) | |||
| Is there a gas station near your house? | 0.112 | ||||||||
| No | 3444 | (74.4) | 3149 | (74.7) | 295 | (71.1) | |||
| Yes | 1186 | (25.6) | 1066 | (25.3) | 120 | (28.9) | |||
| Is there a rubbish dump near your house? | (1.08–2.10) | 0.017 | |||||||
| No | 4270 | (92.2) | 3900 | (92.5) | 370 | (89.2) | 1.00 | ||
| Yes | 360 | (7.8) | 315 | (7.5) | 45 | (10.8) | 1.51 | ||
| Do you smell offensive odors near your house? | (1.54–2.37) | <0.001 | |||||||
| No | 3594 | (77.6) | 3320 | (78.8) | 274 | (66.0) | 1.00 | ||
| Yes | 1036 | (22.4) | 895 | (21.2) | 141 | (34.0) | 1.91 | ||
1 Pearson’s Chi-squared test. 2 CI, confidence interval.
3.5. Lifestyle Habits
The comparison of residential lifestyle between the MCS high-risk group and the control group is shown in Table 5. No statistically significant differences in residential lifestyle were found between the MCS high-risk group and the control group.
Table 5.
Comparison of residential lifestyle between the groups.
| Comparative Items | Total Number n = 4630 (100%) |
Control Group n = 4215 (91.0%) |
High-Risk Group n = 415 (9.0%) |
Crude Odds Ratio (95% CI 2) |
p-Value 1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | ||||
| Use of ventilation, exhaust fans | 0.610 | ||||||||
| Yes | 4081 | (88.1) | 3712 | (88.1) | 369 | (88.9) | |||
| No | 549 | (11.9) | 503 | (11.9) | 46 | (11.1) | |||
| Use of insect repellant | 0.335 | ||||||||
| No | 2780 | (60.0) | 2540 | (60.3) | 240 | (57.8) | |||
| Yes | 1850 | (40.0) | 1675 | (39.7) | 175 | (42.2) | |||
| Use of air fresheners | 0.250 | ||||||||
| No | 1088 | (23.5) | 981 | (23.3) | 107 | (25.8) | |||
| Yes | 3542 | (76.5) | 3234 | (76.7) | 308 | (74.2) | |||
| Use of insecticides, electric mosquito coil | 0.099 | ||||||||
| No | 1928 | (41.6) | 1771 | (42.0) | 157 | (37.8) | |||
| Yes | 2702 | (58.4) | 2444 | (58.0) | 258 | (62.2) | |||
| Use of floor wax | 0.780 | ||||||||
| No | 3030 | (65.4) | 2761 | (65.5) | 269 | (64.8) | |||
| Yes | 1600 | (34.6) | 1454 | (34.5) | 146 | (35.2) | |||
| Extermination of termites and mites | 0.176 | ||||||||
| No | 3784 | (81.7) | 3455 | (82.0) | 329 | (79.3) | |||
| Yes | 846 | (18.3) | 760 | (18.0) | 86 | (20.7) | |||
| Use of agricultural chemicals, herbicides | 0.850 | ||||||||
| No | 3564 | (77.0) | 3243 | (76.9) | 321 | (77.3) | |||
| Yes | 1066 | (23.0) | 972 | (23.1) | 94 | (22.7) | |||
| Use of a kerosene stove | 0.151 | ||||||||
| No | 2242 | (48.4) | 2055 | (48.8) | 187 | (45.1) | |||
| Yes | 2388 | (51.6) | 2160 | (51.2) | 228 | (54.9) | |||
| Use of an air purifier | 0.708 | ||||||||
| Yes | 1868 | (40.3) | 1697 | (40.3) | 171 | (41.2) | |||
| No | 2762 | (59.7) | 2518 | (59.7) | 244 | (58.8) | |||
| Has pets | 0.379 | ||||||||
| No | 2538 | (54.8) | 2302 | (54.6) | 236 | (56.9) | |||
| Yes | 2092 | (45.2) | 1913 | (45.4) | 179 | (43.1) | |||
1 Pearson’s Chi-squared test. 2 CI, confidence interval.
The comparison of lifestyle factors between the MCS high-risk group and the control group is shown in Table 6. The only statistically significant item was “Exercises more than once a week outside of physical education class”, which was significantly lower in the MCS high-risk group.
Table 6.
Comparison of lifestyle factors between the groups.
| Comparative Items | Total Number n = 4630 (100%) |
Control Group n = 4215 (91.0%) |
High-Risk Group n = 415 (9.0%) |
Crude Odds Ratio (95% CI 2) |
p-Value 1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | ||||
| Eats breakfast every day | 0.483 | ||||||||
| Yes | 4184 | (90.4) | 3813 | (90.5) | 371 | (89.4) | |||
| No | 446 | (9.6) | 402 | (9.5) | 44 | (10.6) | |||
| Considers a balanced nutritional intake | 0.095 | ||||||||
| Yes | 2412 | (52.1) | 2212 | (52.5) | 200 | (48.2) | |||
| No | 2218 | (47.9) | 2003 | (47.5) | 215 | (51.8) | |||
| Frequent consumption of instant foods | 0.882 | ||||||||
| No | 2147 | (46.4) | 1956 | (46.4) | 191 | (46.0) | |||
| Yes | 2483 | (53.6) | 2259 | (53.6) | 224 | (54.0) | |||
| Meals are mainly Western cooking | 0.627 | ||||||||
| No | 2896 | (62.5) | 2641 | (62.7) | 255 | (61.4) | |||
| Yes | 1734 | (37.5) | 1574 | (37.3) | 160 | (38.6) | |||
| Frequent consumption of fermented foods such as miso and pickles | 0.094 | ||||||||
| Yes | 3294 | (71.1) | 2984 | (70.8) | 310 | (74.7) | |||
| No | 1336 | (28.9) | 1231 | (29.2) | 105 | (25.3) | |||
| Frequent consumption of vegetables | 0.300 | ||||||||
| Yes | 3427 | (74.0) | 3111 | (73.8) | 316 | (76.1) | |||
| No | 1203 | (26.0) | 1104 | (26.2) | 99 | (23.9) | |||
| Drinking water is from a water purifier or is bought water | 0.147 | ||||||||
| Yes | 1876 | (40.5) | 1694 | (40.2) | 182 | (43.9) | |||
| No | 2754 | (59.5) | 2521 | (59.8) | 233 | (56.1) | |||
| Frequent consumption of green tea from plastic bottles (made from polyethylene terephthalate) | 0.944 | ||||||||
| No | 2105 | (45.5) | 1917 | (45.5) | 188 | (45.3) | |||
| Yes | 2525 | (54.5) | 2298 | (54.5) | 227 | (54.7) | |||
| Exercises more than once a week (outside of physical education class) | 0.006 | ||||||||
| Yes | 2875 | (62.1) | 2643 | (62.7) | 232 | (55.9) | 1.00 | ||
| No | 1755 | (37.9) | 1572 | (37.3) | 183 | (44.1) | 1.33 | ||
| (1.08–1.63) | |||||||||
| Soaks in the bathtub when bathing | 0.712 | ||||||||
| Yes | 2817 | (60.8) | 2561 | (60.8) | 256 | (61.7) | |||
| No | 1813 | (39.2) | 1654 | (39.2) | 159 | (38.3) | |||
| Usage time of PC/smartphone | 0.181 | ||||||||
| Less than 3 h | 2209 | (47.7) | 2024 | (48.0) | 185 | (44.6) | |||
| 3 h or more | 2421 | (52.3) | 2191 | (52.0) | 230 | (55.4) | |||
| Television viewing time | 0.470 | ||||||||
| Less than 2 h | 2220 | (47.9) | 2014 | (47.8) | 206 | (49.6) | |||
| 2 h or more | 2410 | (52.1) | 2201 | (52.2) | 209 | (50.4) | |||
1 Pearson’s Chi-squared test. 2 CI, confidence interval.
The comparison of lifestyle habits and physical/mental conditions between the MCS high-risk group and the control group is shown in Table 7. The MCS high-risk group reported significantly higher rates of “cold hands and feet”, “fatigue”, “subjective stress”, and the number of “yes” responses compared with the control group.
Table 7.
Comparison of lifestyle habits and physical/mental conditions between the groups.
| Comparative Items | Total Number n = 4630 (100%) |
Control Group n = 4215 (91.0%) |
High-Risk Group n = 415 (9.0%) |
Crude Odds Ratio (95% CI 2) |
p-Value 1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| n | (%) | N | (%) | n | (%) | ||||
| Smoking habit 1 | 0.110 | ||||||||
| Non-smoker | 4500 | (97.2) | 4097 | (97.2) | 403 | (97.1) | |||
| Former smoker | 119 | (2.6) | 110 | (2.6) | 9 | (2.2) | |||
| Smoker | 11 | (0.2) | 8 | (0.2) | 3 | (0.7) | |||
| Smoking habit 2 | 0.069 | ||||||||
| Non-smoker or former smoker | 4619 | (99.8) | 4207 | (99.8) | 412 | (99.3) | |||
| Smoker | 11 | (0.2) | 8 | (0.2) | 3 | (0.7) | |||
| Family member who smokes | 0.213 | ||||||||
| No | 1726 | (37.3) | 1583 | (37.6) | 143 | (34.5) | |||
| Yes | 2904 | (62.7) | 2632 | (62.4) | 272 | (65.5) | |||
| Drinking habit | 0.176 | ||||||||
| Does not drink alcohol | 4481 | (96.8) | 4084 | (96.9) | 397 | (95.7) | |||
| Drinks alcohol sometimes or every day | 149 | (3.2) | 131 | (3.1) | 18 | (4.3) | |||
| Cold hands and feet | <0.001 | ||||||||
| No | 2910 | (62.9) | 2702 | (64.1) | 208 | (50.1) | 1.00 | ||
| Yes | 1720 | (37.1) | 1513 | (35.9) | 207 | (49.9) | 1.78 | ||
| (1.45–2.18) | |||||||||
| Fatigue | <0.001 | ||||||||
| No | 2250 | (48.6) | 2111 | (50.1) | 139 | (33.5) | 1.00 | ||
| Yes | 2380 | (51.4) | 2104 | (49.9) | 276 | (66.5) | 1.99 | ||
| (1.61–2.46) | |||||||||
| Hours of sleep | 0.064 | ||||||||
| 7–8 h | 2298 | (49.6) | 2110 | (50.1) | 188 | (45.3) | |||
| 9 h or more or 6 h or less | 2332 | (50.4) | 2105 | (49.9) | 227 | (54.7) | |||
| Bed time | 0.138 | ||||||||
| Before 11 p.m. | 431 | (9.3) | 384 | (9.1) | 47 | (11.3) | |||
| After 11 p.m. | 4199 | (90.7) | 3831 | (90.9) | 368 | (88.7) | |||
| Normal temperature | 0.148 | ||||||||
| 34.5–35.9 °C | 1450 | (31.3) | 1307 | (31.0) | 143 | (34.5) | |||
| 36.0 °C or higher | 3180 | (68.7) | 2908 | (69.0) | 272 | (65.5) | |||
| Subjective stress 1 | <0.001 | ||||||||
| Slight | 1307 | (28.2) | 1247 | (29.6) | 60 | (14.5) | 1.00 | ||
| Moderate–significant | 3323 | (71.8) | 2968 | (70.4) | 355 | (85.5) | 2.49 | ||
| (1.88–3.29) | |||||||||
| Subjective stress 2 | <0.001 | ||||||||
| Slight–moderate | 3826 | (82.6) | 3528 | (83.7) | 298 | (71.8) | 1.00 | ||
| Significant | 804 | (17.4) | 687 | (16.3) | 117 | (28.2) | 2.02 | ||
| (1.60–2.54) | |||||||||
1 Pearson’s Chi-squared test. 2 CI, confidence interval.
3.6. The Three QEESI Category Scores
Intergroup comparisons of the three QEESI category scores are shown in Table 8. These comparisons were made using the Mann–Whitney U test, due to the non-normal distribution of our data. When comparing the median values of the control and MCS high-risk groups across the three QEESI categories (Q1: chemical intolerance, Q3: symptom severity, and Q5: impact on life), all showed significantly higher values in the MCS high-risk group, as indicated by the Mann–Whitney U-test results.
Table 8.
Inter-group comparison of the three QEESI category scores.
| QEESI 2 | Control Group n = 4215 (91.0%) |
High-Risk Group n = 415 (9.0%) |
Difference | p-Value 1 | |
|---|---|---|---|---|---|
| Q1 Chemical Intolerance | Mean ± standard deviation | 16.1 ± 16.0 | 51.7 ± 8.5 | 35.6 | |
| Median (25–75% points) | 12 (2–26) | 50 (46–56) | 38.0 | <0.001 | |
| Minimum to maximum | 0–100 | 40–100 | - | ||
| Q3 Symptom Severity | Mean ± standard deviation | 18.6 ± 15.3 | 45.5 ± 13.6 | 26.9 | |
| Median (25–75% points) | 15 (6–28) | 46 (35–54) | 31.0 | <0.001 | |
| Minimum to maximum | 0–84 | 20–93 | - | ||
| Q5 Life Impact | Mean ± standard deviation | 5.5 ± 7.3 | 25.9 ± 14.3 | 20.4 | |
| Median (25–75% points) | 3 (0–8) | 22 (14–34) | 19.0 | <0.001 | |
| Minimum to maximum | 0–63 | 10–100 | - | ||
1 Mann–Whitney U Test. 2 QEESI, Quick Environment Exposure Sensitivity Inventory.
3.7. Logistic Regression Analysis of Factors Related to the MCS High-Risk Group
The results of the logistic regression analysis of factors related to the MCS high-risk group are shown in Table 9 and Figure 2. When the p value was set at ≤0.25, 32 variables were selected, and when the p value was set at ≤0.15, 25 variables were selected; both methods were stable with nine steps and nine similar variables.
Table 9.
Factors related to the MCS high-risk group based on logistic regression analysis.
| Variables | Univariate Analysis | p-Value 1 | Multivariable Analysis | p-Value 1 | ||
|---|---|---|---|---|---|---|
| Crude Odds Ratio |
95% CI 3 | Adjusted Odds Ratio | 95% CI 3 | |||
| Sex, female [male] 2 | 1.55 | 1.27–1.90 | <0.001 | 1.29 | 1.04–1.60 | 0.020 |
| Atopic dermatitis [no] | 1.38 | 1.08–1.76 | 0.009 | 1.29 | 1.01–1.65 | 0.045 |
| Metal allergies [no] | 2.57 | 1.61–4.11 | <0.001 | 1.79 | 1.11–2.91 | 0.018 |
| Cold hands and feet [no] | 1.78 | 1.45–2.18 | <0.001 | 1.36 | 1.09–1.69 | 0.006 |
| Number of times moving to a new home/one time or more [0 times] |
1.24 | 1.01–1.53 | 0.036 | 1.26 | 1.02–1.55 | 0.030 |
| Offensive odor [no] | 1.91 | 1.54–2.37 | <0.001 | 1.69 | 1.35–2.10 | <0.001 |
| Bedtime [after 11 p.m.] | 0.79 | 1.57–1.08 | 0.138 | 1.40 | 1.01–1.95 | 0.044 |
| Subjective stress 1/moderate–significant [slight] | 2.49 | 1.88–3.29 | <0.001 | 2.02 | 1.51–2.71 | <0.001 |
| Fatigue [no] | 1.99 | 1.61–2.46 | <0.001 | 1.45 | 1.15–1.82 | 0.002 |
| The Hosmer–Lemeshow test resulted in p = 0.976 and the model’s discriminant accuracy was 91.0% | ||||||
1 Pearson’s Chi-squared test. 2 The reference categories are specified in square brackets. 3 CI, confidence interval.
Figure 2.
Factors related to the MCS high-risk group.
The model included nine variables consistently showing significance among the total 57 variables included in the model: “female sex”, “having atopic dermatitis”, “having metal allergies”, “having cold hands and feet”, “being fatigued”, “moving into a new home one or more times”, “exposure to offensive odors”, “bedtime earlier than 11 p.m.”, and “subjective stress: moderate–frequent”. The results of the Chi-squared test for the model were significant (p < 0.001), with each variable individually showing significance as well (p < 0.05). The Hosmer–Lemeshow test was used to examine the predictive accuracy of the model and showed a high degree of predictive accuracy (p = 0.976); the discriminative predictive value was 91.0%.
4. Discussion
In this study, the prevalence of high sensitivity to chemicals (MCS high-risk group) in Japanese high school students was 9.0%, and the following factors were associated with a high risk of MCS among high school students: female sex, having multiple allergies, frequent relocation into a new home (once or more), having experienced home renovations or extensions, proximity to environmental stressors (living near a freeway, national highway, factory, rubbish dump, or source of offensive odors), not exercising once or more per week outside of physical education classes, having cold hands and feet, being fatigued, having a bedtime earlier than 11 p.m., and having moderate–frequent subjective stress.
4.1. Prevalence of MCS-like Symptoms
As mentioned above, the percentage of high school students who were classified as chemically sensitive (MCS high-risk group) according to the QEESI was 9.0%. Previous studies that have used the QEESI have estimated the prevalence to be 20.4% in the United States [15], 8.2% in Denmark [18], 14.4% in South Korea [17], and 7.5% in Japan [34]. However, in those studies, the target population comprised mainly adults and the cut-off values were different; therefore, the estimates cannot be simply compared. Furthermore, in surveys targeting minors, the rate was 15.6% in Sweden (13–19 years old) [35] and 12.4% (6–15 years old) in Japan [12]; however, the data were self-reported and the QEESI was not used. Therefore, a simple comparison is similarly difficult. However, the finding that 9.0% of high school students were in the high-risk group for MCS indicated that 9.0% of high school students exhibited symptoms resembling those associated with MCS, regardless of whether they recognized these symptoms as being related to MCS. It is believed that the awareness of MCS will be improved and the QEESI will be disseminated so that high school students can receive appropriate diagnosis and treatment.
The association between having been diagnosed with SHS and being in the MCS high-risk group was statistically significant; however, there was no association between having been diagnosed with MCS and being in the MCS-high-risk group. This association may not have been significant, due to there being a limited number of students diagnosed with MCS; thus, the results are difficult to interpret. In Japan, MCS is less well known than SHS. Furthermore, diagnostic criteria for MCS have not been established, and MCS presents with various symptoms, making it difficult to see a specialist. In addition, the QEESI scores may have been low because those with severe MCS-like symptoms may not have been able to attend school and take the survey; alternatively, they may have received treatment and reconsidered their lifestyles, leading to the disappearance of symptoms [13,36].
4.2. Allergy-like Symptoms and MCS
In this study, 77.9% of participants had some type of allergy-like symptoms (hay fever, atopic dermatitis, asthma, mold/dust/mite allergy, hives, food allergies, drug allergies, or metal allergies). As previous studies have not assessed the overall prevalence using identical survey items, we present our results by comparing each item with findings from related surveys. Specifically, the figure of 77.9% represents the proportion of individuals experiencing any of the eight specified allergy-like symptoms in our study. To contextualize these findings, we compared the incidence rates of each symptom with those reported in the existing literature. The results of this study are shown first and the results of previous studies are shown in parentheses: hay fever, 61.1% (48.1% [37]); atopic dermatitis, 18.2% (24.7% [38]); asthma, 16.8% (18.8% [39]); mold/dust/mite allergy, 2.7% (18.8% [40]); urticaria, 30.9% (8.8/20% [41,42]); food allergies, 13.8% (16.8% [43]); drug allergies, 2.7% (3.9% [44]); and metal allergies, 2.5% (3% [45]). While direct comparisons are complicated due to variations in factors such as prevalence rate, calculation methods, participant age, country of residence, and survey year, our study’s findings notably indicate relatively high rates of hay fever and urticaria. However, in a survey conducted in Tochigi Prefecture, a prefecture adjacent to Gunma Prefecture where this survey was conducted, 27.7% of elementary and junior high school students answered that they had no allergies [43], which is close to the 22.1% reported in this study. Therefore, it is not unreasonable to consider the reported 77.9% prevalence of allergy-like symptoms among high school students as credible, given the findings from these comparable studies.
Previous studies have reported that MCS is more common in individuals with allergy-like symptoms [21,28,32,34,46] and women [47], and the present study revealed similar results. The number of individuals with allergy-like symptoms is increasing yearly [40], and people with allergy-like symptoms are more likely to develop chemical sensitivity [20,28,29]. There is concern that the number of patients with MCS will increase with an increase in the number of individuals experiencing allergy-like symptoms.
Regarding the types of allergies, atopic dermatitis [32,34,46] and metal allergies [48], which were found to be statistically significant in previous studies, were also significantly associated with the MCS high-risk group in this study. However, regarding bronchial asthma [4,14,49,50], this study found no significant association in either the single or multivariate analyses.
Although the relationship between allergy-like symptoms and MCS requires further investigation, it is necessary to raise awareness of MCS so that people with allergy-like symptoms are aware of the onset of MCS symptoms.
4.3. Factors Related to the MCS High-Risk Group and Prospects for the Prevention of MCS Onset
In this study, we examined factors associated with a high risk of MCS, such as sex, presence of allergy-like symptoms, living environment, and lifestyle.
Regarding sex, the probability of being female in the MCS high-risk group was 1.55 times the probability of being female in the control group; this finding is similar to those of previous studies of adults [32,34,35,47]. In Japan, it is believed that one of the causes of MCS is sick building syndrome and that women are more likely to develop SHS/MCS than men because they spend more time exposed to radiation in homes that emit chemical substances. However, as the participants of this survey were high school students, it is unlikely that the amount of time spent at home differed between men and women, suggesting that there may have been another reason. In the future, we would like to consider the possibility that women have higher percentages of body fat than men and that chemicals are more likely to accumulate there.
Regarding the living environment, the finding that people who had experience of moving into a new house tended to be more likely to develop MCS was similar to findings in previous research [32]. When moving into a new house, renovating, expanding, or remodeling, it is important to select and use materials that emit the smallest possible amount of volatile chemicals and to take measures to ensure that volatile chemicals evaporate sufficiently. However, it is difficult for individuals to improve the environment around their homes, and relocating is not an easy option. Therefore, if there are expressways, national highways, railways, factories, or garbage disposal sites nearby, it is important to take measures as far as possible to prevent exposure to chemical substances [51].
It is understood that as symptoms of MCS increase in severity, sensitivity to odors increases as a protective response against potentially harmful substances [13,51]. This sensitivity also plays a crucial role in encouraging immediate departure from environments or objects emitting unfamiliar odors.
Regarding lifestyle habits, items such as “cold hands and feet”, “feeling of fatigue”, “subjective stress”, “bedtime earlier than 11 p.m.”, and “exercising less than once a week” were associated with the high-risk group for MCS. Regarding “cold hands and feet”, it is believed that “coldness” causes circulatory failure, which causes detoxification and chemical excretion functions to no longer work smoothly. Recently, “Onkatsu”, which refers to warming the body to improve blood circulation and ultimately enhance sensitivity to cold and various other ailments, has been attracting attention in Japan. Further research is expected to determine whether Onkatsu and improving coldness are effective ways to improve and prevent the onset of MCS.
Regarding bedtimes, a study of Japanese children aged 6–15 years stated that later bedtimes were associated with MCS [12]. However, in this study, earlier bedtimes were more common in the MCS high-risk group. It was difficult to compare the results directly because the ages of the survey participants were different. Therefore, further research is needed to investigate the relationship between bedtime and MCS; it is possible that MCS-like symptoms may lead to earlier bedtimes. Regardless, although the recommended bedtime for individuals in this study was unknown, there was an evident relationship between MCS-like symptoms and “bedtime”, “feelings of fatigue”, and “subjective stress”. Hence, stress management and lifestyle adjustments are important.
Regarding the habit of exercising more than once a week, sweating during exercise helps eliminate waste products, increases muscle mass, increases basal metabolism, and creates a constitution that makes it easier to eliminate chemicals. It is expected to be useful in improving and preventing the onset of MCS.
Previous studies have reported that MCS-like symptoms can be improved by improving the air quality in the living environment [13,34,51]. It is necessary to disseminate information about MCS so that people can take measures as far as possible to avoid exposure to chemical substances and incorporate coping methods, such as stress management, lifestyle adjustments, and exercise therapy, to improve and prevent the onset of MCS-like symptoms.
4.4. Strengths and Limitations
This was the first study to examine the prevalence of high-risk MCS and associated factors in high school students. The data obtained from the MCS survey of thousands of high school students are extremely valuable. In addition, with a response rate of 94.0%, the ratio of the MCS high-risk group to the control group within participating schools provides valuable insights for generalization and serves as valuable epidemiological data.
This study also had some limitations. First, this study was conducted in 2013; hence, the current situation may be different. Second, because this study was based on a self-administered questionnaire and was a cross-sectional study, it was not possible to clarify causal relationships, and we could only speculate about the associations. Third, different samples may have yielded different results because of the small number of high school students with MCS-like symptoms. Fourth, this study targeted high school students in Gunma Prefecture, which may have influenced the results of items related to regional characteristics, such as hay fever and the living environment.
5. Conclusions
Overall, the percentage of Japanese high school students who were sensitive to chemical substances (MCS high-risk group) was 9.0%, and 77.9% reported allergy-like symptoms. The following factors were related to a high risk of MCS in high school students: female sex, having various allergic conditions, relocating into a new home once or more, having experienced home renovations or extensions, living near a freeway/national highway/factory/rubbish dump/source of offensive odors, not exercising once or more per week outside of physical education classes, having cold hands and feet, being fatigued, having a bedtime earlier than 11 p.m., and moderate–frequent subjective stress. The results suggest that 9.0% of high school students in Japan are aware of MCS-like symptoms. Addressing allergies, the living environment, and lifestyle habits may lead to the improvement of MCS-like symptoms.
Acknowledgments
We would like to express our deepest gratitude to all the high school students and teachers at each high school who took time out of their busy schedules to cooperate with this research.
Author Contributions
Conceptualization, T.S.; methodology, T.S. and Y.B.; formal analysis, T.S.; investigation, T.S. and Y.B.; data curation, T.S. and Y.B.; writing—original draft preparation, T.S.; writing—review and editing, Y.B.; visualization, T.S. and Y.B.; supervision, Y.O.; project administration, T.S; funding acquisition, T.S. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Gunma PAZ University (protocol code: 13–17; date of approval: 24 July 2013).
Informed Consent Statement
All participating students were provided with clear information stating that their involvement in the study was voluntary and anonymous. The researcher provided informed consent within the survey form. Written informed consent was obtained from all subjects.
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Conflicts of Interest
The authors declare no conflicts of interest.
Funding Statement
This research was funded by a Grant-in-Aid for Challenging Exploratory Research (JSPS KAKENHI; principal investigator: Tamami Suzuki) grant number JP20890213 and a Grant-in-Aid for Scientific Research (C; principal investigator: Tamami Suzuki) grant number JP20K11057.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Molot J., Sears M., Anisman H. Multiple Chemical Sensitivity: It’s Time to Catch up to the Science. Neurosci. Biobehav. Rev. 2023;151:105227. doi: 10.1016/j.neubiorev.2023.105227. [DOI] [PubMed] [Google Scholar]
- 2.Fares-Medina S., Díaz-Caro I., García-Montes R., Corral-Liria I., García-Gómez-Heras S. Multiple Chemical Sensitivity Syndrome: First Symptoms and Evolution of the Clinical Picture: Case-Control Study/Epidemiological Case-Control Study. Int. J. Environ. Res. Public Health. 2022;19:15891. doi: 10.3390/ijerph192315891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Del Casale A., Ferracuti S., Mosca A., Pomes L.M., Fiaschè F., Bonanni L., Borro M., Gentile G., Martelletti P., Simmaco M. Multiple Chemical Sensitivity Syndrome: A Principal Component Analysis of Symptoms. Int. J. Environ. Res. Public Health. 2020;17:6551. doi: 10.3390/ijerph17186551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Steinemann A. National Prevalence and Effects of Multiple Chemical Sensitivities. J. Occup. Environ. Med. 2018;60:e152–e156. doi: 10.1097/JOM.0000000000001272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Zucco G.M., Doty R.L. Multiple Chemical Sensitivity. Brain Sci. 2021;12:46. doi: 10.3390/brainsci12010046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Viziano A., Micarelli A., Pasquantonio G., Della-Morte D., Alessandrini M. Perspectives on Multisensory Perception Disruption in Idiopathic Environmental Intolerance: A Systematic Review. Int. Arch. Occup. Environ. Health. 2018;91:923–935. doi: 10.1007/s00420-018-1346-z. [DOI] [PubMed] [Google Scholar]
- 7.Rossi S., Pitidis A. Multiple Chemical Sensitivity: Review of the State of the Art in Epidemiology, Diagnosis, and Future Perspectives. J. Occup. Environ. Med. 2018;60:138–146. doi: 10.1097/JOM.0000000000001215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.De Luca C., Raskovic D., Pacifico V., Thai J.C.S., Korkina L. The Search for Reliable Biomarkers of Disease in Multiple Chemical Sensitivity and Other Environmental Intolerances. Int. J. Environ. Res. Public Health. 2011;8:2770–2797. doi: 10.3390/ijerph8072770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Bartha L. Multiple Chemical Sensitivity: A 1999 Consensus. Arch. Environ. Health. 1999;54:147–149. doi: 10.1080/00039899909602251. [DOI] [PubMed] [Google Scholar]
- 10.Lacour M., Zunder T., Schmidtke K., Vaith P., Scheidt C. Multiple Chemical Sensitivity Syndrome (MCS)--Suggestions for an Extension of the U.S. MCS-Case Definition. Int. J. Hyg. Environ. Health. 2005;208:141–151. doi: 10.1016/j.ijheh.2005.01.017. [DOI] [PubMed] [Google Scholar]
- 11.Miller C.S., Prihoda T.J. The Environmental Exposure and Sensitivity Inventory (EESI): A Standardized Approach for Measuring Chemical Intolerances for Research and Clinical Applications. Toxicol. Ind. Health. 1999;15:370–385. doi: 10.1177/074823379901500311. [DOI] [PubMed] [Google Scholar]
- 12.Nagayoshi M., Sugita O., Hashimoto A., Kobayashi K., Noriko H., Iiyoshi Y., Soda K., Murooka K., Sakamoto C. Questionnaire resurvey on multiple chemical sensitivity-like symptoms in school students (6–15 years of age) Indoor Environ. 2013;16:97–103. doi: 10.7879/siej.16.97. [DOI] [Google Scholar]
- 13.Perales R.B., Palmer R.F., Rincon R., Viramontes J.N., Walker T., Jaén C.R., Miller C.S. Does Improving Indoor Air Quality Lessen Symptoms Associated with Chemical Intolerance? Prim. Health Care Res. Dev. 2022;23:e3. doi: 10.1017/S1463423621000864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nynäs P., Vilpas S., Kankare E., Karjalainen J., Lehtimäki L., Numminen J., Tikkakoski A., Kleemola L., Huhtala H., Uitti J. Multiple Chemical Sensitivity in Patients Exposed to Moisture Damage at Work and in General Working-Age Population-The SAMDAW Study. Int. J. Environ. Res. Public Health. 2021;18:12296. doi: 10.3390/ijerph182312296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Palmer R.F., Walker T., Kattari D., Rincon R., Perales R.B., Jaén C.R., Grimes C., Sundblad D.R., Miller C.S. Validation of a Brief Screening Instrument for Chemical Intolerance in a Large U.S. National Sample. Int. J. Environ. Res. Public Health. 2021;18:8714. doi: 10.3390/ijerph18168714. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Pérez-Crespo J., Lobato-Cañón R., Solanes-Puchol Á. Multiple Chemical Sensitivity in Chemical Laboratory Workers. Saf. Health Work. 2018;9:473–478. doi: 10.1016/j.shaw.2018.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Heo Y., Kim S.-H., Lee S.-K., Kim H.-A. Factors Contributing to the Self-Reported Prevalence of Multiple Chemical Sensitivity in Public Facility Workers and the General Population of Korea. J. UOEH. 2017;39:249–258. doi: 10.7888/juoeh.39.249. [DOI] [PubMed] [Google Scholar]
- 18.Skovbjerg S., Berg N.D., Elberling J., Christensen K.B. Evaluation of the Quick Environmental Exposure and Sensitivity Inventory in a Danish Population. J. Environ. Public Health. 2012;2012:304314. doi: 10.1155/2012/304314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hojo S., Kumano H., Yoshino H., Kakuta K., Ishikawa S. Application of Quick Environment Exposure Sensitivity Inventory (QEESI) for Japanese Population: Study of Reliability and Validity of the Questionnaire. Toxicol. Ind. Health. 2003;19:41–49. doi: 10.1191/0748233703th180oa. [DOI] [PubMed] [Google Scholar]
- 20.Hojo S., Ishikawa S., Kumano H., Miyata M., Sakabe K. Clinical Characteristics of Physician-Diagnosed Patients with Multiple Chemical Sensitivity in Japan. Int. J. Hyg. Environ. Health. 2008;211:682–689. doi: 10.1016/j.ijheh.2007.09.007. [DOI] [PubMed] [Google Scholar]
- 21.Manabe R., Kunugita N., Katoh T., Kuroda Y., Akiyama Y., Yamano Y., Uchiyama I., Arashidani K. Questionnaire Survey of Workers in Specific Buildings Regarding Multiple Chemical Sensitivity. Nihon Eiseigaku Zasshi. 2008;63:717–723. doi: 10.1265/jjh.63.717. [DOI] [PubMed] [Google Scholar]
- 22.Fujimori S., Hiura M., Yi C.X., Xi L., Katoh T. Factors in Genetic Susceptibility in a Chemical Sensitive Population Using QEESI. Environ. Health Prev. Med. 2012;17:357–363. doi: 10.1007/s12199-011-0260-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Cui X., Lu X., Hiura M., Oda M., Miyazaki W., Katoh T. Evaluation of Genetic Polymorphisms in Patients with Multiple Chemical Sensitivity. PLoS ONE. 2013;8:e73708. doi: 10.1371/journal.pone.0073708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Suzuki K., Okamura M., Haruyama Y., Suzuki S., Shiina T., Kobashi G., Hirata K. Exploring the Contributing Factors to Multiple Chemical Sensitivity in Patients with Migraine. J. Occup. Health. 2022;64:e12328. doi: 10.1002/1348-9585.12328. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Nogué S., Fernández-Solá J., Rovira E., Montori E., Fernández-Huerta J.M., Munné P. Multiple Chemical Sensitivity: Study of 52 Cases. Med. Clin. 2007;129:96–98. doi: 10.1157/13107370. [DOI] [PubMed] [Google Scholar]
- 26.Nordin S., Andersson L. Evaluation of a Swedish Version of the Quick Environmental Exposure and Sensitivity Inventory. Int. Arch. Occup. Environ. Health. 2010;83:95–104. doi: 10.1007/s00420-009-0427-4. [DOI] [PubMed] [Google Scholar]
- 27.Andersson M.J.E., Andersson L., Bende M., Millqvist E., Nordin S. The Idiopathic Environmental Intolerance Symptom Inventory: Development, Evaluation, and Application. J. Occup. Environ. Med. 2009;51:838–847. doi: 10.1097/JOM.0b013e3181a7f021. [DOI] [PubMed] [Google Scholar]
- 28.Katerndahl D.A., Bell I.R., Palmer R.F., Miller C.S. Chemical Intolerance in Primary Care Settings: Prevalence, Comorbidity, and Outcomes. Ann. Fam. Med. 2012;10:357–365. doi: 10.1370/afm.1346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Heinonen-Guzejev M., Koskenvuo M., Mussalo-Rauhamaa H., Vuorinen H.S., Heikkilä K., Kaprio J. Noise Sensitivity and Multiple Chemical Sensitivity Scales: Properties in a Population Based Epidemiological Study. Noise Health. 2012;14:215–223. doi: 10.4103/1463-1741.102956. [DOI] [PubMed] [Google Scholar]
- 30.Mena G., Sequera V.-G., Nogué-Xarau S., Ríos J., Bertran M.J., Trilla A. Translation and Cross-Cultural Adaptation of the Quick Environmental Exposure and Sensitivity Inventory for use in the Spanish Population. Med. Clin. 2013;140:302–304. doi: 10.1016/j.medcli.2012.10.024. [DOI] [PubMed] [Google Scholar]
- 31.Alobid I., Nogué S., Izquierdo-Dominguez A., Centellas S., Bernal-Sprekelsen M., Mullol J. Multiple Chemical Sensitivity Worsens Quality of Life and Cognitive and Sensorial Features of Sense of Smell. Eur. Arch. Otorhinolaryngol. 2014;271:3203–3208. doi: 10.1007/s00405-014-3015-5. [DOI] [PubMed] [Google Scholar]
- 32.Jeong I., Kim I., Park H.J., Roh J., Park J.-W., Lee J.-H. Allergic Diseases and Multiple Chemical Sensitivity in Korean Adults. Allergy Asthma Immunol. Res. 2014;6:409–414. doi: 10.4168/aair.2014.6.5.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Heilbrun L.P., Palmer R.F., Jaen C.R., Svoboda M.D., Perkins J., Miller C.S. Maternal Chemical and Drug Intolerances: Potential Risk Factors for Autism and Attention Deficit Hyperactivity Disorder (ADHD) J. Am. Board Fam. Med. 2015;28:461–470. doi: 10.3122/jabfm.2015.04.140192. [DOI] [PubMed] [Google Scholar]
- 34.Azuma K., Uchiyama I., Katoh T., Ogata H., Arashidani K., Kunugita N. Prevalence and Characteristics of Chemical Intolerance: A Japanese Population-Based Study. Arch. Environ. Occup. Health. 2015;70:341–353. doi: 10.1080/19338244.2014.926855. [DOI] [PubMed] [Google Scholar]
- 35.Andersson L., Johansson A., Millqvist E., Nordin S., Bende M. Prevalence and Risk Factors for Chemical Sensitivity and Sensory Hyperreactivity in Teenagers. Int. J. Hyg. Environ. Health. 2008;211:690–697. doi: 10.1016/j.ijheh.2008.02.002. [DOI] [PubMed] [Google Scholar]
- 36.Ohsawa M., Takayama S., Kikuchi A., Arita R., Saito N., Hojo S., Ishii T., Yaegashi N. Two Cases of Multiple Chemical Sensitivity Successfully Treated With Kampo Medicine. Altern. Ther. Health Med. 2021;27:54–58. [PubMed] [Google Scholar]
- 37.Yamada T., Saito H., Fujieda S. Present State of Japanese Cedar Pollinosis: The National Affliction. J. Allergy Clin. Immunol. 2014;133:632–639.e5. doi: 10.1016/j.jaci.2013.11.002. [DOI] [PubMed] [Google Scholar]
- 38.Nishijima H., Suzuki S., Kondo K., Yamasoba T., Yanagimoto S. Environmental Factors Associated with Allergic Rhinitis Symptoms in Japanese University Students: A Cross-Sectional Study. Auris Nasus Larynx. 2018;45:1006–1013. doi: 10.1016/j.anl.2018.02.004. [DOI] [PubMed] [Google Scholar]
- 39.Sugiyama K., Sugiyama T., Toda M., Yukawa T., Makino S., Fukuda T. Prevalence of Asthma, Rhinitis and Eczema among 13-14-Year-Old Schoolchildren in Tochigi, Japan. Allergol. Int. 2000;49:205–211. doi: 10.1046/j.1440-1592.2000.00180.x. [DOI] [Google Scholar]
- 40.Sakashita M., Tsutsumiuchi T., Kubo S., Tokunaga T., Takabayashi T., Imoto Y., Kato Y., Yoshida K., Kimura Y., Kato Y., et al. Comparison of Sensitization and Prevalence of Japanese Cedar Pollen and Mite-Induced Perennial Allergic Rhinitis between 2006 and 2016 in Hospital Workers in Japan. Allergol. Int. 2021;70:89–95. doi: 10.1016/j.alit.2020.07.004. [DOI] [PubMed] [Google Scholar]
- 41.Zuberbier T., Balke M., Worm M., Edenharter G., Maurer M. Epidemiology of Urticaria: A Representative Cross-Sectional Population Survey. Clin. Exp. Dermatol. 2010;35:869–873. doi: 10.1111/j.1365-2230.2010.03840.x. [DOI] [PubMed] [Google Scholar]
- 42.Zuberbier T., Abdul Latiff A.H., Abuzakouk M., Aquilina S., Asero R., Baker D., Ballmer-Weber B., Bangert C., Ben-Shoshan M., Bernstein J.A., et al. The International EAACI/GA2LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis, and Management of Urticaria. Allergy. 2022;77:734–766. doi: 10.1111/all.15090. [DOI] [PubMed] [Google Scholar]
- 43.Abid H., Ando Y., Miyamoto M., Yoshihara S. Using a Survey, Analyzing the Current Situation of Allergic March in Elementary and Junior High School Students of Oyama and Tochigi Cities, Japan. Pediatr. Neonatol. 2024 doi: 10.1016/j.pedneo.2023.10.008. in press . [DOI] [PubMed] [Google Scholar]
- 44.Rebelo Gomes E., Fonseca J., Araujo L., Demoly P. Drug Allergy Claims in Children: From Self-Reporting to Confirmed Diagnosis. Clin. Exp. Allergy. 2008;38:191–198. doi: 10.1111/j.1365-2222.2007.02870.x. [DOI] [PubMed] [Google Scholar]
- 45.Thyssen J.P., Menné T. Metal Allergy—A Review on Exposures, Penetration, Genetics, Prevalence, and Clinical Implications. Chem. Res. Toxicol. 2010;23:309–318. doi: 10.1021/tx9002726. [DOI] [PubMed] [Google Scholar]
- 46.Azuma K., Uchiyama I., Kunugita N. Factors Affecting Self-Reported Chemical Intolerance: A Five-Year Follow-up Study in Japan. J. Psychosom. Res. 2019;118:1–8. doi: 10.1016/j.jpsychores.2019.01.001. [DOI] [PubMed] [Google Scholar]
- 47.Black D.W., Doebbeling B.N., Voelker M.D., Clarke W.R., Woolson R.F., Barrett D.H., Schwartz D.A. Multiple Chemical Sensitivity Syndrome: Symptom Prevalence and Risk Factors in a Military Population. Arch. Intern. Med. 2000;160:1169–1176. doi: 10.1001/archinte.160.8.1169. [DOI] [PubMed] [Google Scholar]
- 48.Pigatto P.D., Minoia C., Ronchi A., Brambilla L., Ferrucci S.M., Spadari F., Passoni M., Somalvico F., Bombeccari G.P., Guzzi G. Allergological and Toxicological Aspects in a Multiple Chemical Sensitivity Cohort. Oxid. Med. Cell. Longev. 2013;2013:356235. doi: 10.1155/2013/356235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Steinemann A. International Prevalence of Chemical Sensitivity, Co-Prevalences with Asthma and Autism, and Effects from Fragranced Consumer Products. Air Qual. Atmos. Health. 2019;12:519–527. doi: 10.1007/s11869-019-00672-1. [DOI] [Google Scholar]
- 50.Hojo S., Mizukoshi A., Azuma K., Okumura J., Mizuki M., Miyata M. New Criteria for Multiple Chemical Sensitivity Based on the Quick Environmental Exposure and Sensitivity Inventory Developed in Response to Rapid Changes in Ongoing Chemical Exposures among Japanese. PLoS ONE. 2019;14:e0215144. doi: 10.1371/journal.pone.0215144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Suzuki T., Ohno Y., Bai Y., Inoue M. Research into the Symptoms of Sick House Syndrome and/or Multiple Chemical Sensitivity Patients and Indoor and Outdoor Air Quality. IT Healthcare. 2011;6:154–166. doi: 10.11204/ithc.6.154. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.